β2-microglobulin kinetics during haemodialysis and haemofiltration

Nephrology Dialysis Transplantation

Volumn 1, Issue 4, 1987, Pages 223-228

  Fluge J ^a   Granolleras, C ^b   Bingel, M ^a   Deschodt, G ^b   Branger, B ^b   Oules, R ^b   Koch, K M ^a   Shaldon, S ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b University of Nîmes   (France)

Author keywords

Amyloidosis; Haemodialysis; Haemofiltration; 2 Microglobulin

Indexed keywords

BETA 2 MICROGLOBULIN;

AMYLOIDOSIS; CLINICAL ARTICLE; DIALYSIS MEMBRANE; HEMODIALYSIS; HEMOFILTRATION; HUMAN;

ADULT; AMYLOIDOSIS; BETA 2-MICROGLOBULIN; BLOOD; CELLULOSE; COMPARATIVE STUDY; FEMALE; HUMAN; KIDNEY FAILURE, CHRONIC; KIDNEY, ARTIFICIAL; KINETICS; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGE; POLYMERS; RENAL DIALYSIS; SULFONES; ULTRAFILTRATION;

EID: 0023489331     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a091481     Document Type: Article

References (23)

1. Assenat H, Calemard E, Charra B, Laurent G, Terrat JC, Vanel T. 5 Hemodialyse. Syndrome du canal carpien et substance amyloide. Pressemédm 1980;9:1715.
2. Bardin T, Kuntz D, Zingraff J, Voisin MC, Zelmar A, Lansaman J. Synovial amyloidosis in patients undergoing longterm hemodialysis. S Arthritis Rheum 1985; 28:1052-1058.
3. DiRaimondo CR, Casey TT, DiRaimondo CV, Stone WJ. Pathologic fractures associated with idiopathic amyloidosis of bone in chronic 2 hemodialysis patients. Nephron 1986; 43:22-27.
4. Vandenbroucke JM, Jadoul M, Maldagne B, Huaux JP, Noel H, Vang Ypersele de Strihou C. Possible role of dialysis membrane characteristics in amyloid osteoarthropathy (letter). Lancet 1986; 1: 1210-1211.
5. Gejyo F, Yaraada T, Odani S et al. A new form of amyloid protein associated with chronic hemodialysis was identified as beta-2-microglobulin. Biochem Biophys Res Commun 1985; 129: 701-706.
6. Gorevic PD, Casey TT, Stone WJ, DiRaimondo CR, Prelli FC, Frangione B. Beta-2-microglobulin is an amyloidogenic protein in man. J Clin Invest 1985; 76: 2425-2429.
7. Bardin T, Kuntz D, Zingraff J et al. Synovial amyloidosis and beta-2-microglobulin in patients undergoing longterm hemodialysis (letter). Arthrit Rheum 1986; 29:453-454.
8. Vincent C, Revillard JP, Galland M, Traeger J. Serum beta-2-microglobulin in hemodialysed patients. Nephron 1978; 21:260-268.
9. Connors LH, Shirahama T, Skinner M, Fenves A, Cohen AS. In vitro formation of amyloid fibrils from intact beta-2-microglobulin. Biochem Biophys Res Commun 1985; 131:1063-1068.
10. Shaldon S, Deschodt G, Granolleras C et al. Experience with on line hemofiltration. In: Atsumi K, Maekawa M, Ota K, eds. Progress in Artificial Organs—1983, Vol 2, Cleveland, ISAO Press No. 204, 1984: 586-589.
11. Mayr HU, Stec F, Canaud B, Mion CM, Shaldon S. Microbiological aspects of the batch preparation of replacement fluid for hemofiltration. Blood Purification 1984; 2:158-163.
12. Sargent JA, Gotch FA. Principles and biophysics of dialysis. In: Drukker W, Parsons FM, Maher JF, eds. Replacement of renal function by dialysis. Boston, Nijhoff Publishers, 1983: 53-96.
13. Wibell L, Evrin PE, Berggard I. Serum beta-2-microglobulin in renal disease. Nephron 1973; 10:320-331.
14. Vincent C, Pozet N, Revillard JP. Plasma beta-2-microglobulin turnover in renal insufficiency. Ada Clin Belg 1980; 35 [Suppl] 10:2-13.
15. Fakir M, Toupance O, Roujouleh H et al. Carpal tunnel syndrome in chronic hemodialysis patients (abstr.). In: Contemporary management of renal failure. Hospal International Forum, Marakech, November 1985: 17.
16. Herve JP, Pennec Y, Cledes J et al. Carpal tunnel syndrome, cystic bone lesions, rhizomelic rhumatism in long-term hemodialysis, a multicentric survey (abstr.). In: Contemporary management of renal failure. Hospal International Forum, Marakech, November 1985:17.
17. Bommer J, Seelig HP, Seelig R, Ritz E. Beta-2-microglobulin levels in hemodialysed patients. In press.
18. Gejyo F, Homma N, Suzuki Y, Arakawa M. Serum levels of beta-2-microglobulin as a new form of amyloid protein in patients undergoing longterm hemodialysis. N Engl J Med (letter) 1985; 314: 585.
19. Henderson LW, Koch KM, Dinarello CA, Shaldon S. Hemodialysis hypotension: the interleukin hypothesis. Blood Purification 1983; 1:3-8.
20. Collins T, Lapierre LA, Friers W, Strominger J, Pober JS. Recombinant tumor necrosis factor increases mRNA levels and surface expression of HLA-A, B antigens in vascular endothelial cells and dermofibroblasts in vitro. Proc NatlAcadSci USA 1986: 83:446-450.
21. Hakim RM, Fearon DT, Lazarus JM. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 1984; 26: 194-200.
22. Lonnemann G, Bingel M, Floge J, Shaldon S, Dinarello CA, Koch KM. Passage of interleukin-1 inducing factors through the intact dialyzer membrane. In press.
23. Koch KM, Shaldon S, Baldamus CA, Lysaght MJ, Lonnemann G, Bingel M, Dinarello CA. Convective mass transport in dialysis. Proc Eur Dial Transplant Assoc 1985; 22:155-160.